Goldman Sachs Group »

Indivior Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $73M 2.4M 30.48

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Tesla CMN (TSLA)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN (HYG)
Taiwan Semiconductor Manufac CMN (TSM)

View all positions for Goldman Sachs Group

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals